doi: 10.1016/j.neubiorev.2015.07.015 419 MissailidisDSanislavOAllanCYAnnesleySJFisherPR
Type 2 Diabetes Medications and Stomach Paralysis The type 2 diabetes medications used for weight loss are classified as GLP-1 receptor agonists and are made with ingredients that make the patient feel full, sooner than they normally would
Instead, you begin low and increase gradually over weeks, giving your body time to adjust and minimizing the gastrointestinal side effects that come with GLP-1 receptor activation
While it is not a cure, studies indicate that it may help manage symptoms and improve quality of life
These effects are mediated by: Improved endothelial function and nitric oxide bioavailability Reduced vascular inflammation and oxidative stress Stabilization of atherosclerotic plaque Enhanced cardiac metabolism and mitochondrial efficiency From a longevity standpoint, microdosing may maintain low-grade GLP-1 receptor activation within vascular tissue, supporting arterial flexibility, autonomic tone, and lipid regulation without the gastrointestinal intolerance often limiting high-dose use